Concepedia

Myrna Candelaria

MC

40

Publications

2.1K

Citations

28

H-Index

1997

Active since

Affiliations

Instituto Nacional de Cancerología(Current)

Universidad Nacional Autónoma de México

Universidad de Cuautitlán Izcalli

Myrna Candelaria is an author at Instituto Nacional de Cancerología specializing in medicine, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

1997–2021

40

Publications

40

A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors

Myrna Candelaria, Dolores Gallardo‐Rincón, Claudia Arce et al. · Annals of Oncology · 2007 · 249 citations

, , +7

A Proof-Of-Principle Study of Epigenetic Therapy Added to Neoadjuvant Doxorubicin Cyclophosphamide for Locally Advanced Breast Cancer

Claudia Arce, Carlos Pérez‐Plasencia, Aurora González‐Fierro et al. · PLoS ONE · 2006 · 144 citations · Full text

Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines

Alma Chávez‐Blanco, Carlos Pérez‐Plasencia, Enrique Pérez‐Cárdenas et al. · Cancer Cell International · 2006 · 142 citations · Full text

A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results

Jaime Coronel, Lucely Cetina, Irlanda Pacheco et al. · Medical Oncology · 2010 · 131 citations

, , +10

Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study

Alma Chávez‐Blanco, Blanca Segura-Pacheco, Enrique Pérez‐Cárdenas et al. · Molecular Cancer · 2005 · 127 citations · Full text

Rows per page

1–5 of 40